Search Videos and More
2026 Practice-Changing Updates in Bladder, Kidney, & Prostate Cancers
Date: November 18, 20262027 Atlantic Regional Hematopathology Meeting:
Future Directions in Hematopathology
Expand Treatment Options for Patients with Peritoneal Metastases
With an Early Cytoreduction Surgical Evaluation
The Storied Career Of Clinical Physicist Dr. Charlie Ma: From Philadelphia To Cancer Centers Worldwide
Over more than two decades at Fox Chase Cancer Center, Chang Ming Charlie Ma, PhD, FAAPM, FASTRO, Professor, Director of Physics, and Vice Chair of Radiation Oncology, helped transform clinical physics from a behind-the-scenes discipline into a force that reshaped how radiation therapy is planned, calculated, and delivered.A Randomized Phase II/III Trial of Intraperitoneal Paclitaxel Plus Systemic Treatment vs Systemic Treatment Alone in Gastric Carcinomatosis – STOPGAP II (EA2234)
Can we lower the chance of gastric cancer from growing or spreading by administering paclitaxel chemotherapy directly into the abdominal cavity in addition to chemotherapy given through a vein in the arm? Will administering paclitaxel chemotherapy directly into the abdominal cavity, in addition to chemotherapy given through a vein in the arm help patients live longer?Prehabilitation in High-Risk Oncologic Surgery: A Prospective Cohort Study (PRS III)
The goal of this clinical study is to learn whether a prehabilitation program can improve recovery after major abdominal surgery in adults with cancer who are receiving treatment before surgery.Fox Chase Cancer Center at ASTRO 2026
We are pleased to highlight several Fox Chase–Temple sessions taking place at ASTRO 2026. Explore the sessions below as our faculty and residents share their work throughout the meeting — and be sure to visit us at Booth #1336 in the ASTRO Exhibit Hall.Adaptive Radiation Boost for Rectal Cancer (ARBOR)
The goal of this clinical trial is to find out if giving extra adaptive radiation therapy after standard chemoradiation treatment is safe and helpful for people with rectal cancer.Adaptive Radiation for Locally Advanced Unresectable Pancreatic Cancer
The goal of this clinical trial is to learn if Adaptive Radiation Therapy (ART) is safe and effective in treating patients with locally advanced pancreatic cancer.Redefining Treatment Timelines for Platinum-Resistant Ovarian Cancer
“Integrating clinical trials and newer therapies earlier in a patient’s ovarian cancer treatment journey can make a significant difference in their outcome,” said Angela Jain, MD, Associate Professor, Department of Hematology/Oncology; Chief, Division of Gynecologic Medical Oncology; and Clinical Director of GYN/Well Women’s Health Clinical Service Line.Philadelphia Lung Cancer Symposium
Join us for the Philadelphia Lung Cancer Symposium, a dynamic, multidisciplinary education program featuring expert faculty from leading Philadelphia institutions, hosted by Fox Chase Cancer Center (FCCC) in collaboration with Penn Medicine’s Abramson Cancer Center. This full-day symposium—led by Program Directors Hossein Borghaei, DO, MS (FCCC) and Charu Aggarwal, MD, MS (Abramson Cancer Center)—delivers a high-impact review of evolving standards in early-stage disease, small cell lung cancer, targeted therapies, and emerging approaches shaping practice in 2026 and beyond.Expanding the Role and Responsibilities of Urologic Advanced Practice Providers
Since 2024, the Fox Chase – Temple Urologic Institute has grown exponentially, increasing demand for highly trained advanced practice providers (APPs) to work alongside attending specialists. Recently, eight new APPs have joined the team to address the expanding clinical needs in both urologic oncology and general urology, with clinic appointments often exceeding capacity.

